These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19608600)

  • 21. Random effects and latent processes approaches for analyzing binary longitudinal data with missingness: a comparison of approaches using opiate clinical trial data.
    Albert PS; Follmann DA
    Stat Methods Med Res; 2007 Oct; 16(5):417-39. PubMed ID: 17656452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjusting for drop-out in clinical trials with repeated measures: design and analysis issues.
    Wu MC; Albert PS; Wu BU
    Stat Med; 2001 Jan; 20(1):93-108. PubMed ID: 11135350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of alternative strategies for analysis of longitudinal trials with dropouts.
    Liu G; Gould AL
    J Biopharm Stat; 2002 May; 12(2):207-26. PubMed ID: 12413241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of dropouts on sample size estimates for test on trends across repeated measurements.
    Ahn C; Jung SH
    J Biopharm Stat; 2005; 15(1):33-41. PubMed ID: 15702603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Shared random parameter models: A legacy of the biostatistics program at the National Heart, Lung, and Blood Institute.
    Albert PS
    Stat Med; 2019 Feb; 38(4):501-511. PubMed ID: 30376693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dirichlet negative multinomial regression for overdispersed correlated count data.
    Farewell DM; Farewell VT
    Biostatistics; 2013 Apr; 14(2):395-404. PubMed ID: 23221819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The gradient function as an exploratory goodness-of-fit assessment of the random-effects distribution in mixed models.
    Verbeke G; Molenberghs G
    Biostatistics; 2013 Jul; 14(3):477-90. PubMed ID: 23376427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing missing data assumptions in longitudinal studies: an example using a smoking cessation trial.
    Yang X; Shoptaw S
    Drug Alcohol Depend; 2005 Mar; 77(3):213-25. PubMed ID: 15734221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bayesian bivariate linear mixed-effects models with skew-normal/independent distributions, with application to AIDS clinical studies.
    Huang Y; Chen R; Dagne G; Zhu Y; Chen H
    J Biopharm Stat; 2015; 25(3):373-96. PubMed ID: 24897242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Joint modeling of hierarchically clustered and overdispersed non-gaussian continuous outcomes for comet assay data.
    Ghebretinsae AH; Faes C; Molenberghs G; Geys H; Van der Leede BJ
    Pharm Stat; 2012; 11(6):449-55. PubMed ID: 22997130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance of selected nonparametric tests for discrete longitudinal data under different patterns of missing data.
    Chirwa TF; Bogaerts J; Chirwa ED; Kazembe LN
    J Biopharm Stat; 2009; 19(1):190-203. PubMed ID: 19127475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of the generalized estimating equation approach with the maximum likelihood approach for repeated measurements.
    Park T
    Stat Med; 1993 Sep; 12(18):1723-32. PubMed ID: 8248664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A general class of pattern mixture models for nonignorable dropout with many possible dropout times.
    Roy J; Daniels MJ
    Biometrics; 2008 Jun; 64(2):538-45. PubMed ID: 17900312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bayesian informative dropout model for longitudinal binary data with random effects using conditional and joint modeling approaches.
    Chan JS
    Biom J; 2016 May; 58(3):549-69. PubMed ID: 26467236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modelling variable dropout in randomised controlled trials with longitudinal outcomes: application to the MAGNETIC study.
    Kolamunnage-Dona R; Powell C; Williamson PR
    Trials; 2016 Apr; 17(1):222. PubMed ID: 27125779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A mixture of hierarchical joint models for longitudinal data with heterogeneity, non-normality, missingness, and covariate measurement error.
    Huang Y; Yan C; Yin P; Lu M
    J Biopharm Stat; 2016; 26(2):299-322. PubMed ID: 25629642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A bias correction in testing treatment efficacy under informative dropout in clinical trials.
    Kong F; Chen YF; Jin K
    J Biopharm Stat; 2009 Nov; 19(6):980-1000. PubMed ID: 20183460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Marginalized transition shared random effects models for longitudinal binary data with nonignorable dropout.
    Lee M; Lee K; Lee J
    Biom J; 2014 Mar; 56(2):230-42. PubMed ID: 24430985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Testing treatment effect in schizophrenia clinical trials with heavy patient dropout using latent class growth mixture models.
    Kong F; Chen YF
    Pharm Stat; 2016 Jul; 15(4):349-61. PubMed ID: 27169874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Joint modeling of repeated multivariate cognitive measures and competing risks of dementia and death: a latent process and latent class approach.
    Proust-Lima C; Dartigues JF; Jacqmin-Gadda H
    Stat Med; 2016 Feb; 35(3):382-98. PubMed ID: 26376900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.